Skip to main content
logo
Krebs Biochemicals & Industries Limited (BOM:524518)
India flag India · Delayed Price · Currency is INR
55.88
-0.28 (-0.50%)
At close: Nov 6, 2026

BOM:524518 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
268.57237.32433.12504.22521.34597.03
Revenue Growth
-1.32%-45.21%-14.10%-3.29%-12.68%13.32%
Gross Profit
241.21224.11332.81410.23244.19155.85
Operating Income
-61.6-99.68-212.91-151.95-218.46-394.94
Net Income
-133.49-169.33-269.39-197.28-246.92-445.27
Earnings Per Share
-6.19-7.85-12.49-9.15-11.45-20.65
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1.261.291.421.370.861.01
Total Debt
2,2702,2482,1221,9371,8341,431
Net Cash (Debt)
-2,269-2,247-2,121-1,935-1,833-1,430
Net Cash Growth
------
Net Cash Per Share
-105.26-104.22-98.36-89.77-85.01-66.32

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
27.53-19.21-78.9123.65-247.13-172.16
Capital Expenditures
-20.13-31.72-35.63-94.15-151.58-270.78
Free Cash Flow
7.4-50.92-114.54-70.5-398.71-442.95
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
89.81%94.43%76.84%81.36%46.84%26.11%
Operating Margin
-22.94%-42.00%-49.16%-30.14%-41.90%-66.15%
Pretax Margin
-49.70%-71.35%-62.16%-39.13%-47.36%-74.58%
Profit Margin
-49.70%-71.35%-62.20%-39.13%-47.36%-74.58%
FCF Margin
2.76%-21.46%-26.45%-13.98%-76.48%-74.19%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
4.493.643.332.612.335.18